A Blog by AMCP CEO Susan A. Cantrell, RPh, CAE

AMCP_Beyond 

 

  

Welcome Remarks at General Session of AMCP Annual Meeting 2018 in Boston

 

 

SusanGS18 

May 2, 2018 

Hello! Welcome to Boston and the Academy of Managed Care Pharmacy’s Annual Meeting!  

It is my pleasure to stand here before you at this pivotal moment in the history of our country’s health care system. As we just saw, the way we deliver care is undergoing a sweeping transformation by forces that require new thinking and innovation. 

Glance at any news outlet today and you’ll see story after story on the trends buffeting health care:  

  •  Headline: skyrocketing costs place enormous burdens on patients and payers alike. 
  •  Headline: breakthrough therapies come with astronomical price tags.  
  •  Headline: a flood of state and federal legislative proposals aim to control drug prices. 

And, fundamentally,  

  • Headline: How viable is the U.S. health care system? 

Transformative? Disruptive? I think so! 

And AMCP’s response? It’s no longer business-as-usual. The urgency of these headlines cannot be ignored. Health care spending increased by almost 5 percent last year to reach nearly $3.5 trillion dollars. And the average cost of prescription drugs between 2005 and 2015 has increased by more than 172 percent. 

But there’s a bright spot to this picture.  Just look at some of the new, innovative therapies that are revolutionizing the way we treat diseases today. And managed care pharmacy supports and welcomes this remarkable innovation. But it’s clear we need to free up space in the health care ecosystem to pay for these products.  

That’s why AMCP’s top priorities for policy and advocacy this year include: addressing the rising cost of medications; and shifting away from fee-for-service payment and towards value-based models. 

And we need you – our members – to play a crucial role in this effort! Together, we can address the challenging headlines to make effective medicines available and affordable. And we can avoid some of the more extreme solutions being put forth that may have unintended consequences. 

Fortunately, AMCP is ideally positioned to make this happen. We are leading on a host of promising initiatives that address the rising cost of medications, and shift us towards value-based models. We start by bringing together all the important stakeholders to discuss the issues and propose solutions.  This year we will be discussing ways: 

  • To manage the total cost of patient care across the medical and pharmacy benefits;  
  •  To designing new payment models for expensive, high-investment medications; 
  •  To better use patient-reported outcomes as a measure of value; and 
  •  To implement value-based agreements in integrated delivery networks. 

These efforts will be aided by the AMCP Foundation, which has the twin missions of advancing education and conducting research. Just yesterday the Joint AMCP and AMCP Foundation Research Committee approved a research agenda that will identify and prioritize critical evidentiary gaps in managed care pharmacy. In the past, our Foundation provided invaluable research into such topics as maximizing value in health care, and addressing the medicine affordability crisis. And the Foundation will continue to its body of knowledge on Emerging Trends in Health Care.  

These current efforts continue AMCP’s long tradition of driving health care transformation. We are very proud of our role in: 

  • Promoting legislation to allow for the exchange of information on medications prior to FDA approval;  
  • Helping design and support the Medicare Part D program; and 
  • Generating evidence on the safety and efficacy of biologics and biosimilars through the creation  of the Biologics and Biosimilars Collective Intelligence Consortium, or BBCIC as we call it.    

On the topic of biosimilars, we're delighted the FDA is taking steps to spur competition around these products. We're also delighted that FDA Commissioner Scott Gottlieb has recognized AMCP's offer of support [on Twitter]. It seems Twitter is where policy announcements are made these days.” 

We have the ideas, the talent, the evidence-based data and the respect to address today’s most pressing headlines.  

But AMCP is not only adapting to meet external challenges. We are continually evolving to meet the challenges and needs of you, our members.  

You are the reason we are all here. We don’t forget that! AMCP aims to be your essential partner in helping you perform your job and advance your career.  

And, of course, we will continue to provide you with the very best educational opportunities possible…through events such as this Annual Meetings and our fall Nexus conference. I would like to thank our Meeting sponsors who help make this possible! 

AMCP turns 30 this year…and yet it feels like we’ve just begun! What keeps us fresh and nimble — and dare I say youthful — is our laser focus on always improving and pushing boundaries. We have never been more energized…never been more driven…and never been more excited to help our members carry out the mission of “improving health care for all!” 

 

  

Not All Scientific Journals Are Created Equal: Beware of Predatory Publishers

 

 

April 4, 2018 

Usually I delete emails like the one I received recently, but this one got me thinking. It was addressed to one of my predecessors, and invited her to publish a paper in a journal on patient care and nursing. The message said, “We believe that your invaluable experience and insights as a scholar in the area will be enlightening to our readers.”

Well, the former CEO of the Academy did indeed have “invaluable experience,” just not in the areas of patient care or nursing, at least to my knowledge. Read more.

 

  

AMCP Legislative Days Focuses on Passage of PIE Act, Efforts to Reduce Fraud, Waste and Abuse in Medicare Part D

 

 

March 7, 2018 

One of AMCP’s key strategic pillars is to advocate for legislation that will help advance the profession of managed care pharmacy. This function is on full display this week during our Annual Legislative Days event. I am proud to join nearly 20 of AMCP’s volunteer leaders and staff in a trek up Capitol Hill to meet with more than 50 House and Senate offices on two crucial issues:  

  • Passage of the Pharmaceutical Information Exchange (PIE) Act of 2018 (H.R. 2026).
  • Initiatives to reduce fraud, waste and abuse under the Medicare Part D program.

Visit http://amcp.org/AMCPPositions/. Read more. 

 

  

PIE Act Addresses Lag Between FDA Approval and Patient Access; Cantrell Makes Case for H.R. 2026 in The Hill 

 

 

February 7, 2018 

The FDA approved 46 novel drugs in 2017, a 21-year high. However, it could take as long as six months for some of these groundbreaking medicines to reach patients, as pharmaceutical review committees work their way through complex clinical information to determine how, when, and why a new drug should be prescribed. The way things stand now, the insurers and pharmacy benefits managers (PBMs) that set copayments, premiums, and reimbursement rates do not receive reliable data about a new treatment until it is approved by the FDA. But it can take months to assess that information and establish appropriate prescribing standards, meet state health insurance rate filings, fulfill Medicare and Medicaid requirements, and negotiate contracts with health care purchasers.

Read Cantrell’s full op-ed at bit.ly/2DQpuIZ  

 

 

New Strategic Plan Built on Close Look at Sector Changes and Challenges 

 

January 5, 2017 

I am delighted to announce the release of our new strategic plan, AMCP 2020, which will guide and strengthen the Academy as we enter our 30th year of serving thousands of professionals who make up managed care pharmacy. Read more.

 

 

The Strategic Planning That Goes into Developing AMCP's New Strategic Plan 

 
Dec. 6, 2017

The Academy will soon unveil a new strategic plan to guide our organization over the next several years. As it’s rolled out ‒ more on that next month ‒ I thought I would highlight some of the deliberations that went into developing the plan. Read more.

 

 

Speech at General Session of AMCP Nexus 2017 

 
October 31, 2017

It’s wonderful to be here in Texas. AMCP has many longtime members and friends from the great Lone Star State, including many from right here in the Dallas region. We also have many members from the Houston area. Our heart goes out to everyone in Texas affected by Hurricane Harvey, as well as all of the other recent storms and now the wild fires in California. Read more.

 

 

 

As the ACA's Future Remains in Limbo, PIE Legislation Moves Steadily Forward

 
September 28, 2017

Health care reform historically has been one of the most contentious issues on Capitol Hill. The current fight to repeal the Affordable Care Act (ACA) is just the latest in a string of battles that reaches back many decades, including to the founding of Medicare and Medicaid. Read more.

   

AMCP Offers Prayers, Collects Items for Victims of Hurricane Harvey; Will Deliver Portion of Socks Collected by AMCP Foundation to Houston Charities

 
September 5, 2017

Like everyone across the country, AMCP members and staff share a deep concern for the safety and wellbeing of thousands of people displaced by Hurricane Harvey. Read More.
 
   

NEJM Article on ‘Accelerated Approvals and Expensive Drugs’ Misses Promising Solution 

 

 August 21, 2017  

A recent article in The New England Journal of Medicine (NEJM) caught my attention for a couple of reasons. Read More

 

Leading on Today’s Most Pressing Challenges: AMCP Partnership Forum Develops Action Plan for Advancing Value-Based Contracting 

 
 

June 29, 2017 

One of the many things that I’m proud of at AMCP is our role as a convener. We bring together several times a year key stakeholders representing a diverse range of positions to address common health care challenges. Read More. 

 
 

My Recent "Field Trip" to Arizona Highlights AMCP's Breadth and Depth

 
 

May 31, 2017 

One maxim I hold dear is the value of getting out of the office now and then to see how things are working in the field. I had that opportunity recently with a “field trip” to the beautiful state of Arizona, where I participated in several events: a workshop on strategies to strengthen association governance, a conference on integrating data in pharmacy practice, a visit with student pharmacists, and a tour of an innovative MTM service center. ... Read more

 
 

AMCP Nexus 2017 Theme Announced: “Changing the Way We Pay for Health Care”

 
 

May 2, 2017 

Volume to value, quantity to quality: such transitions in health care today are like a rock tossed in a pond. The ripple effects are far-reaching and unstoppable. So important is this transformation that we’re dedicating a significant amount of programming to the topic at our fall conference in Dallas (Oct. 16-19). In fact, we’re calling it “AMCP Nexus 2017: Changing the Way We Pay for Health Care.” ... Read more.

 
 

Eye on the Hill: AMCP Sees Progress in PIE Bill and Will Continue to Promote Comprehensive Pharmacy Benefit in Health Care Reform Efforts

 
 

April 11, 2017 

Whoever said, “May you live in interesting times,” could have been talking about Congressional health care policy debates circa 2017. Never a dull moment!

Many things are happening on the health care legislative front, and AMCP has been in the thick of it. ... Read more.

 
 

Ripped from the Headlines - Annual Meeting Sessions Tackle Real-life Issues 

 
 

March 1, 2017 

Every morning — like many of you — I settle behind my desk, take a sip of coffee and read the AMCP Daily Dose. This publication, full of valuable news and information, frequently highlights issues and individuals we’re featuring at our Annual Meeting, March 27-30, in Denver. Several caught my eye recently. ... Read more.

 
 

AMCP Celebrates Early Win: FDA Issues Draft Guidance to Improve Communications Between Biopharmaceutical Companies and Population Health Decision Makers

 
 

February 1, 2017 

Sometimes the best laid plans are upended when you least expect it!

In mid-January, the FDA released draft guidance to facilitate the sharing of information between biopharmaceutical companies and population health decision makers. To say we were pleasantly surprised is an understatement. ... Read more.

 
 

Making PIE to Better Serve Patients

 
 

January 11, 2017 

Let’s imagine you’re a big city mayor and it’s time to order a new fleet of police cars for next year. Applying due diligence, you set out to compare various models from a variety of manufacturers. ... Read more.

 
 

Century Cures Act Advances AMCP's FDAMA Goals, Improves Value-Based Communications Between Manufacturers and Managed Care Pharmacy

 
 

December 22, 2016 

Who says Congress can’t get anything done…and with bipartisan support to boot? With impressive speed and purpose, the House and Senate overwhelmingly passed the 21st Century Cures Act in the waning days of the 114th Congress, followed by President Obama’s prompt signature. ... Read more.

 
 

Pharmacy Profession Comes Together to Help Document and Improve Patient Outcomes Through Medication Therapy Management

 
 

November 7, 2016 

People can accomplish remarkable things when they work toward a common goal. That’s what happened recently when a diverse group of pharmacy stakeholders gathered to develop standardized terms for medication therapy management (MTM) services. ... Read more.

 
 

AMCP really knows how to get things done!

 
 

October 13, 2016 

Not long ago a respected individual in the health care arena told one of my senior staff: “Compared to other associations I work with, AMCP really knows how to get things done.” You cannot imagine how proud I felt ... Read more.

 
 

AMCP Volunteers Are a Happy Lot

 
 

September 20, 2016 

There are many ways to measure the health and vitality of a professional association. The most crucial indicators, I’ve found, center on the engagement of an organization’s volunteers. This can be measured in the number of volunteer opportunities provided, the number of members who sign up, and the level of satisfaction they get from volunteering. ... Read more.

 
 

The Post Cites Pharmacists’ Expanding Role on Medical Teams

 
 

August 26, 2016 

Last week I saw a headline that jumped off the page: “America’s other drug problem: Giving the elderly too many prescriptions” (Washington Post, Aug. 15). I couldn’t read it fast enough and encourage members to do likewise, as it highlights two of the most important developments in health care. ... Read more.

 
 

Seizing Opportunity: AMCP Nexus 2016 Offers Knowledge, Advancement and More

 
 

August 3, 2016 

“Healing is a matter of time, but it is sometimes also a matter of opportunity,” said the great Hippocrates, father of western medicine.

Opportunity, in fact, is a crucial element in the work that managed care pharmacy professionals engage in every day to improve the health, wellbeing and “healing” of millions of patients. We seize opportunities to find the right medicines for the right patients at the right time. ... Read more.

 
 

BRC Now Lets You Look It Up

 
 

July 13, 2016 

It was only ten years ago when biosimilars were so new that the New York Times described them as “so-called.” As late as five years ago newspapers put quotation marks around the term, as in “biosimilars.” At the time some still called them “follow-on” biopharmaceutics. ... Read more.

 
 

Is FDAMA Section 114 Finally Ready for Prime Time?

 
 

June 24, 2016 

Information is the life blood of managed care pharmacy. Of the “competent and reliable scientific” variety, that is.

Our profession operates best when we have broad access to the latest evidence-based data on the multitude of products coming to market today. We can plan, we can assess. With this information, managed care pharmacy professionals can help health care providers and patients select the right drug for the right patient at the right time, while making appropriate use of our scarce health care dollars. ... Read more.

 
 

Getting it straight with the updated AMCP Format!

 
 

May 19, 2016 

Using the best evidence possible to make informed health care decisions is a hallmark of managed care pharmacy. But making sense of the data often is no easy task, especially when it comes to analyzing pharmaceuticals and the value they bring to patients and the health care system... Read more.

 
 

CEO Susan Cantrell Addresses AMCP Annual Meeting

 
 

May 10, 2016 

New&Views announces a new monthly column by CEO Susan A. Cantrell, RPh, CAE, on breaking news and critical issues. Her first column presents her recent address―her first to the membership―at AMCP’s recent Annual Meeting.

“It is truly an honor to be standing before you today as the Academy’s new CEO. While new to the AMCP staff, I’ve been an observer and at times a participant in the terrific work of this organization. ..." Read more.